Meal replacement system for Diabetes Mellitus, Type 2

Phase-Based Progress Estimates
Loma Linda University Health, Loma Linda, CA
Diabetes Mellitus, Type 2+2 More
Meal replacement system - DietarySupplement
All Sexes
What conditions do you have?

Study Summary

This trial is testing a meal replacement system to see if it can help people with Type 2 Diabetes go into remission without the use of medications. In this trial, patients with diabetes will be given a meal replacement system in order to treat their condition. This is not a placebo-based trial, so all patients will receive the treatment. The meal replacement system has been previously approved by the FDA for another condition.

Eligible Conditions

  • Diabetes Mellitus, Type 2
  • Obesity

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Diabetes Mellitus, Type 2

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: Change between baseline and six month visit.

Change between baseline and six month visit.
Efficacy of plant-based meal replacement system on A1-C levels
Efficacy of plant-based meal replacement system on insulin levels

Trial Safety

Safety Progress

1 of 3

Other trials for Diabetes Mellitus, Type 2

Trial Design

2 Treatment Groups

Standard of Care Group
1 of 2
Intervention Group
1 of 2
Active Control
Experimental Treatment

50 Total Participants · 2 Treatment Groups

Primary Treatment: Meal replacement system · No Placebo Group · N/A

Intervention GroupExperimental Group · 2 Interventions: Meal replacement system, Intensive lifestyle Intervention · Intervention Types: DietarySupplement, Behavioral
Standard of Care GroupNoIntervention Group · 1 Intervention: Standard of Care Group · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: change between baseline and six month visit.
Closest Location: Loma Linda University Health · Loma Linda, CA
Photo of california 1Photo of california 2Photo of california 3
2010First Recorded Clinical Trial
1 TrialsResearching Diabetes Mellitus, Type 2
13 CompletedClinical Trials

Who is running the clinical trial?

Loma Linda UniversityLead Sponsor
281 Previous Clinical Trials
257,090 Total Patients Enrolled
5 Trials studying Diabetes Mellitus, Type 2
56,240 Patients Enrolled for Diabetes Mellitus, Type 2
Warren Peters, MDPrincipal InvestigatorLoma Linda University Health
1 Previous Clinical Trials
100 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are a man or woman.
You have been diagnosed with diabetes for less than five years.
You are taking at least one oral agents for diabetes.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.